LRBA Activators
Researchers have explored compounds that indirectly influence LRBA activity by targeting related pathways. For example, autophagy modulators like Chloroquine have been studied for their effects on vesicle trafficking and autophagy, processes closely linked to LRBA function. Immune-modulating agents like Cyclosporin A and Tofacitinib have been used to manage autoimmune diseases, potentially impacting LRBA's role in immune regulation. Additionally, inhibitors of signaling pathways such as TGF-beta or IL-2 have been investigated for their ability to indirectly influence LRBA-related immune responses.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Inhibits lysosomal acidification and autophagy, indirectly affecting LRBA-related processes. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
An immunosuppressive drug that modulates immune responses, potentially influencing LRBA function. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
An autophagy inhibitor that indirectly impacts LRBA-related processes like vesicle trafficking. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that may indirectly impact LRBA-related pathways by modulating MAPK signaling. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
A polyphenol found in green tea with antioxidant properties, possibly affecting LRBA-related signaling pathways. | ||||||